WallStreetZenWallStreetZen

NYSE: FMS
Fresenius Medical Care Ag Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their FMS stock forecasts and price targets.

Forecast return on equity

Is FMS forecast to generate an efficient return?

Company
11.21%
Industry
-113.14%
Market
209.94%
FMS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is FMS forecast to generate an efficient return on assets?

Company
4.7%
Industry
12.71%
FMS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

FMS earnings per share forecast

What is FMS's earnings per share in the next 3 years based on estimates from 23 analysts?

Avg 1 year Forecast
$4.15+187.77%
Avg 2 year Forecast
$4.71+226.83%
Avg 3 year Forecast
$5.59+287.78%
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

FMS revenue forecast

What is FMS's revenue in the next 3 years based on estimates from 24 analysts?

Avg 1 year Forecast
$20.3B-12.03%
Avg 2 year Forecast
$21.2B-8.32%
Avg 3 year Forecast
$22.7B-1.86%
FMS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

FMS earnings growth forecast

How is FMS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
56.51%
Industry
16.79%
Market
40.57%
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
FMS's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

FMS revenue growth forecast

How is FMS forecast to perform vs Medical Care Facilities companies and vs the US market?

Company
-0.59%
Industry
5.61%
Market
23.02%
FMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
FMS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

FMS vs Medical Care Facility Stocks

TickerPricePrice TargetUp/downsideConsensus
FMS$23.78N/AN/A
UHS$222.87$238.10+6.83%Buy
EHC$107.72$148.00+37.39%Strong Buy
ENSG$176.52$206.50+16.98%Strong Buy
THC$207.01$229.80+11.01%Strong Buy
View Top Medical Care Facility Stocks

Fresenius Medical Care Ag Stock Forecast FAQ

What is FMS's earnings growth forecast for 2026-2028?

(NYSE: FMS) Fresenius Medical Care Ag's forecast annual earnings growth rate of 56.51% is forecast to beat the US Medical Care Facilities industry's average forecast earnings growth rate of 16.79%, and it is also forecast to beat the US market's average forecast earnings growth rate of 40.57%.

Fresenius Medical Care Ag's earnings in 2026 is $835,101,162.On average, 23 Wall Street analysts forecast FMS's earnings for 2026 to be $1,201,945,526, with the lowest FMS earnings forecast at $681,724,674, and the highest FMS earnings forecast at $1,406,057,140. On average, 20 Wall Street analysts forecast FMS's earnings for 2027 to be $1,365,072,502, with the lowest FMS earnings forecast at $755,578,180, and the highest FMS earnings forecast at $1,637,356,583.

In 2028, FMS is forecast to generate $1,619,646,814 in earnings, with the lowest earnings forecast at $1,423,419,091 and the highest earnings forecast at $2,026,884,555.

If you're new to stock investing, here's how to buy Fresenius Medical Care Ag stock.

What is FMS's revenue growth forecast for 2026-2028?

(NYSE: FMS) Fresenius Medical Care Ag's forecast annual revenue growth rate of -0.59% is not forecast to beat the US Medical Care Facilities industry's average forecast revenue growth rate of 5.61%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 23.02%.

Fresenius Medical Care Ag's revenue in 2026 is $22,840,469,767.On average, 24 Wall Street analysts forecast FMS's revenue for 2026 to be $5,892,338,816,654, with the lowest FMS revenue forecast at $5,649,445,416,666, and the highest FMS revenue forecast at $6,258,997,708,044. On average, 21 Wall Street analysts forecast FMS's revenue for 2027 to be $6,141,029,195,162, with the lowest FMS revenue forecast at $5,891,469,269,876, and the highest FMS revenue forecast at $6,616,381,433,802.

In 2028, FMS is forecast to generate $6,573,483,792,754 in revenue, with the lowest revenue forecast at $6,114,942,791,822 and the highest revenue forecast at $7,136,660,255,972.

What is FMS's forecast return on assets (ROA) for 2026-2029?

(NYSE: FMS) forecast ROA is 4.7%, which is lower than the forecast US Medical Care Facilities industry average of 12.71%.

What is FMS's Earnings Per Share (EPS) forecast for 2026-2028?

(NYSE: FMS) Fresenius Medical Care Ag's current Earnings Per Share (EPS) is $1.42. On average, analysts forecast that FMS's EPS will be $4.15 for 2026, with the lowest EPS forecast at $2.35, and the highest EPS forecast at $4.85. On average, analysts forecast that FMS's EPS will be $4.71 for 2027, with the lowest EPS forecast at $2.61, and the highest EPS forecast at $5.65. In 2028, FMS's EPS is forecast to hit $5.59 (min: $4.91, max: $6.99).

What is FMS's forecast return on equity (ROE) for 2026-2029?

(NYSE: FMS) forecast ROE is 11.21%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.